These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 34169661)

  • 41. Vaccination with early ferroptotic cancer cells induces efficient antitumor immunity.
    Efimova I; Catanzaro E; Van der Meeren L; Turubanova VD; Hammad H; Mishchenko TA; Vedunova MV; Fimognari C; Bachert C; Coppieters F; Lefever S; Skirtach AG; Krysko O; Krysko DV
    J Immunother Cancer; 2020 Nov; 8(2):. PubMed ID: 33188036
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Intelligent photothermal dendritic cells restart the cancer immunity cycle through enhanced immunogenic cell death.
    Sun Z; Deng G; Peng X; Xu X; Liu L; Peng J; Ma Y; Zhang P; Wen A; Wang Y; Yang Z; Gong P; Jiang W; Cai L
    Biomaterials; 2021 Dec; 279():121228. PubMed ID: 34717198
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Dying to Be Noticed: Epigenetic Regulation of Immunogenic Cell Death for Cancer Immunotherapy.
    Cruickshank B; Giacomantonio M; Marcato P; McFarland S; Pol J; Gujar S
    Front Immunol; 2018; 9():654. PubMed ID: 29666625
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Co-delivery of proanthocyanidin and mitoxantrone induces synergistic immunogenic cell death to potentiate cancer immunotherapy.
    Qian Y; Mao J; Leng X; Zhu L; Rui X; Jin Z; Jiang H; Liu H; Zhang F; Bi X; Chen Z; Wang J
    Biomater Sci; 2022 Aug; 10(16):4549-4560. PubMed ID: 35790120
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Imiquimod Exerts Antitumor Effects by Inducing Immunogenic Cell Death and Is Enhanced by the Glycolytic Inhibitor 2-Deoxyglucose.
    Huang SW; Wang ST; Chang SH; Chuang KC; Wang HY; Kao JK; Liang SM; Wu CY; Kao SH; Chen YJ; Shieh JJ
    J Invest Dermatol; 2020 Sep; 140(9):1771-1783.e6. PubMed ID: 32035924
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Combining Nanomedicine and Immunotherapy.
    Shi Y; Lammers T
    Acc Chem Res; 2019 Jun; 52(6):1543-1554. PubMed ID: 31120725
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Emerging photodynamic nanotherapeutics for inducing immunogenic cell death and potentiating cancer immunotherapy.
    Zhang S; Wang J; Kong Z; Sun X; He Z; Sun B; Luo C; Sun J
    Biomaterials; 2022 Mar; 282():121433. PubMed ID: 35202933
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Immunogenic Cell Death Amplified by Co-localized Adjuvant Delivery for Cancer Immunotherapy.
    Fan Y; Kuai R; Xu Y; Ochyl LJ; Irvine DJ; Moon JJ
    Nano Lett; 2017 Dec; 17(12):7387-7393. PubMed ID: 29144754
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Targeting CAMKII to reprogram tumor-associated macrophages and inhibit tumor cells for cancer immunotherapy with an injectable hybrid peptide hydrogel.
    Dai X; Meng J; Deng S; Zhang L; Wan C; Lu L; Huang J; Hu Y; Zhang Z; Li Y; Lovell JF; Wu G; Yang K; Jin H
    Theranostics; 2020; 10(7):3049-3063. PubMed ID: 32194854
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Synthetic Immunogenic Cell Death Mediated by Intracellular Delivery of STING Agonist Nanoshells Enhances Anticancer Chemo-immunotherapy.
    Chattopadhyay S; Liu YH; Fang ZS; Lin CL; Lin JC; Yao BY; Hu CJ
    Nano Lett; 2020 Apr; 20(4):2246-2256. PubMed ID: 32160474
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Dual functional immunostimulatory polymeric prodrug carrier with pendent indoximod for enhanced cancer immunochemotherapy.
    Wan Z; Sun J; Xu J; Moharil P; Chen J; Xu J; Zhu J; Li J; Huang Y; Xu P; Ma X; Xie W; Lu B; Li S
    Acta Biomater; 2019 May; 90():300-313. PubMed ID: 30930305
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Multifunctional silica nanocomposites prime tumoricidal immunity for efficient cancer immunotherapy.
    Yang L; Li F; Cao Y; Liu Q; Jing G; Niu J; Sun F; Qian Y; Wang S; Li A
    J Nanobiotechnology; 2021 Oct; 19(1):328. PubMed ID: 34663354
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Tumor microenvironment remodeling and tumor therapy based on M2-like tumor associated macrophage-targeting nano-complexes.
    Han S; Wang W; Wang S; Yang T; Zhang G; Wang D; Ju R; Lu Y; Wang H; Wang L
    Theranostics; 2021; 11(6):2892-2916. PubMed ID: 33456579
    [No Abstract]   [Full Text] [Related]  

  • 54. Rediscovery of nanoparticle-based therapeutics: boosting immunogenic cell death for potential application in cancer immunotherapy.
    Yang S; Sun IC; Hwang HS; Shim MK; Yoon HY; Kim K
    J Mater Chem B; 2021 May; 9(19):3983-4001. PubMed ID: 33909000
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Mitochondria-targeted and ultrasound-responsive nanoparticles for oxygen and nitric oxide codelivery to reverse immunosuppression and enhance sonodynamic therapy for immune activation.
    Ji C; Si J; Xu Y; Zhang W; Yang Y; He X; Xu H; Mou X; Ren H; Guo H
    Theranostics; 2021; 11(17):8587-8604. PubMed ID: 34373760
    [No Abstract]   [Full Text] [Related]  

  • 56. Exosomes derived from γδ-T cells synergize with radiotherapy and preserve antitumor activities against nasopharyngeal carcinoma in immunosuppressive microenvironment.
    Wang X; Zhang Y; Mu X; Tu CR; Chung Y; Tsao SW; Chan GC; Leung WH; Lau YL; Liu Y; Tu W
    J Immunother Cancer; 2022 Feb; 10(2):. PubMed ID: 35105688
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Multifunctional carbon monoxide nanogenerator as immunogenic cell death drugs with enhanced antitumor immunity and antimetastatic effect.
    Xiao X; Liang S; Zhao Y; Pang M; Ma P; Cheng Z; Lin J
    Biomaterials; 2021 Oct; 277():121120. PubMed ID: 34508956
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Enhancing TNBC Chemo-immunotherapy via combination reprogramming tumor immune microenvironment with Immunogenic Cell Death.
    Wu S; Liu D; Li W; Song B; Chen C; Chen D; Hu H
    Int J Pharm; 2021 Apr; 598():120333. PubMed ID: 33540008
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Recent progress in stimuli-responsive nanosystems for inducing immunogenic cell death.
    Banstola A; Poudel K; Kim JO; Jeong JH; Yook S
    J Control Release; 2021 Sep; 337():505-520. PubMed ID: 34314800
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The inducers of immunogenic cell death for tumor immunotherapy.
    Li X
    Tumori; 2018; 104(1):1-8. PubMed ID: 28967094
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.